revealed that inhibiting the interaction between FAP+ fibroblasts and SPP1+ macrophages could improve immunotherapy for colorectal cancer.[31] Our research has yielded further evidence supporting the potential involvement of the CCL2‐CCR2 axis in BC recurrence and the feasibility of an anti‐tumor strategy targeting intercellular crosstalk. The gene discussed is SPP1; the disease is breast cancer.